Author:
Thompson Mark G.,Burgess Jefferey L.,Naleway Allison L.,Tyner Harmony L.,Yoon Sarang K.,Meece Jennifer,Olsho Lauren E.W.,Caban-Martinez Alberto J.,Fowlkes Ashley,Lutrick Karen,Kuntz Jennifer L.,Dunnigan Kayan,Odean Marilyn J.,Hegmann Kurt T.,Stefanski Elisha,Edwards Laura J.,Schaefer-Solle Natasha,Grant Lauren,Ellingson Katherine,Groom Holly C.,Zunie Tnelda,Thiese Matthew S.,Ivacic Lynn,Wesley Meredith G.,Lamberte Julie Mayo,Sun Xiaoxiao,Smith Michael E.,Phillips Andrew L.,Groover Kimberly D.,Yoo Young M.,Gerald Joe,Brown Rachel T.,Herring Meghan K.,Joseph Gregory,Beitel Shawn,Morrill Tyler C.,Mak Josephine,Rivers Patrick,Harris Katherine M.,Hunt Danielle R.,Arvay Melissa L.,Kutty Preeta,Fry Alicia M.,Gaglani Manjusha
Publisher
Centers for Disease Control MMWR Office
Subject
Health Information Management,Health, Toxicology and Mutagenesis,General Medicine,Health (social science),Epidemiology
Reference10 articles.
1. Efficacy and safety of the mRNA-123 SARS-CoV-2 vaccine.;Baden;N Engl J Med,2021
2. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine.;Polack;N Engl J Med,2020
3. Pawlowski C, Lenehan P, Puranik A, FDA-authorized COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system. medRxiv [Preprint posted online February 27, 2021]. https://www.medrxiv.org/content/10.1101/2021.02.15.21251623v3
4. Hall VJ, Foulkes S, Saei A, Effectiveness of BNT162b2 mRNA vaccine against infection and COVID-19 vaccine coverage in healthcare workers in England, multicentre prospective cohort study (the SIREN Study). Lancet [Preprint posted online February 22, 2021]. https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3790399
5. Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients.;Amit;Lancet,2021